[Translation] Phase II clinical trial of safety and efficacy of amoxicillin sodium and clavulanate potassium for injection (10:1) randomized, blinded, active drug parallel control in the treatment of bacterial infections
以注射用阿莫西林钠舒巴坦钠为对照药,评价国家化学药品注册分类3.2类新药注射用阿莫西林钠克拉维酸钾(10:1)治疗急性中、重度细菌感染(包括呼吸道感染、泌尿系统感染)的安全性和有效性,同时考察部分病例对阿莫西林耐药菌株所致感染的有效性。
[Translation] Taking Amoxicillin Sodium and Sulbactam Sodium for Injection as the control drug, the treatment of acute moderate and severe bacterial infections (including respiratory tract infections) was evaluated by amoxicillin sodium and clavulanate potassium for injection (10:1), a new drug of National Chemical Drug Registration Category 3.2. , urinary tract infection), and investigate the efficacy of some cases against infections caused by amoxicillin-resistant strains.